trending Market Intelligence /marketintelligence/en/news-insights/trending/bRvZTzhfuG1ifPnDrGz-_A2 content esgSubNav
In This List

Akorn passes US FDA reinspection of facility in Decatur, Illinois

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Akorn passes US FDA reinspection of facility in Decatur, Illinois

The U.S. FDA completed its reinspection of Akorn Inc.'s facility in Decatur, Ill.

The reinspection is a follow-up to verify the implementation and effectiveness of Akorn's responses to the FDA's observations from a June inspection of the facility, which constituted six violations of the Food Drug and Cosmetic Act.